ArticlePloS one2019
An analysis and metric of reusable data licensing practices for biomedical resources.
Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Eras of bioinformatics technologies from command-line interfaces to artificial intelligence (AI) chatbots.Briefings in bioinformatics · 2026Review
- FAIR in practice: minimum metadata schema for bioinformatics analytics by machines.Journal of biomedical semantics · 2026Article
- Desiderata for a biomedical knowledge network: opportunities, challenges and future directions.Bioinformatics advances · 2026Article
- Desiderata for a biomedical knowledge network: opportunities, challenges and future Directions.ArXiv · 2025Article
- Article
- The Water Health Open Knowledge Graph.Scientific data · 2025Article
- We must discuss research environments.Royal Society open science · 2024Article
- The O3 guidelines: open data, open code, and open infrastructure for sustainable curated scientific resources.Scientific data · 2024Article
- Daily life in the Open Biologist's second job, as a Data Curator.Wellcome open research · 2024Article
- COVID-19-related research data availability and quality according to the FAIR principles: A meta-research study.PloS one · 2024Article
- Building a FAIR image data ecosystem for microscopy communities.Histochemistry and cell biology · 2023Review
- Sharing biological data: why, when, and how.FEBS letters · 2021Article
- From Reductionism to Reintegration: Solving society's most pressing problems requires building bridges between data types across the life sciences.PLoS biology · 2021Article
- Dataset Reuse: Toward Translating Principles to Practice.Patterns (New York, N.Y.) · 2020Article
- Transforming the study of organisms: Phenomic data models and knowledge bases.PLoS computational biology · 2020Review
- The case for open science: rare diseases.JAMIA open · 2020Review
- The Monarch Initiative in 2019: an integrative data and analytic platform connecting phenotypes to genotypes across species.Nucleic acids research · 2020Article
- Open Humans: A platform for participant-centered research and personal data exploration.GigaScience · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Data are the foundation of science, and there is an increasing focus on how data can be reused and enhanced to drive scientific discoveries. However, most seemingly "open data" do not provide legal permissions for reuse and redistribution. The inability to integrate and redistribute our collective data resources blocks innovation and stymies the creation of life-improving diagnostic and drug selection tools. To help the biomedical research and research support communities (e.g. libraries, funders, repositories, etc.) understand and navigate the data licensing landscape, the (Re)usable Data Project (RDP) (http://reusabledata.org) assesses the licensing characteristics of data resources and how licensing behaviors impact reuse. We have created a ruleset to determine the reusability of data resources and have applied it to 56 scientific data resources (e.g. databases) to date. The results show significant reuse and interoperability barriers. Inspired by game-changing projects like Creative Commons, the Wikipedia Foundation, and the Free Software movement, we hope to engage the scientific community in the discussion regarding the legal use and reuse of scientific data, including the balance of openness and how to create sustainable data resources in an increasingly competitive environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.